QIAGEN N.V.
QGEN
$45.42
-$0.18-0.40%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.15% | 3.31% | 0.66% | 0.62% | -1.90% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.15% | 3.31% | 0.66% | 0.62% | -1.90% |
| Cost of Revenue | -26.55% | 44.34% | 40.90% | 44.38% | 42.59% |
| Gross Profit | 34.75% | -17.73% | -20.04% | -21.47% | -24.04% |
| SG&A Expenses | 0.18% | -1.17% | -2.56% | -3.20% | -4.17% |
| Depreciation & Amortization | -16.74% | -13.94% | -9.10% | -7.31% | -2.73% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -15.22% | 17.70% | 16.21% | 17.14% | 16.35% |
| Operating Income | 221.98% | -45.57% | -52.43% | -56.77% | -63.26% |
| Income Before Tax | 400.98% | -67.30% | -71.81% | -72.61% | -76.36% |
| Income Tax Expenses | 363.95% | -48.21% | -57.57% | -74.80% | -67.13% |
| Earnings from Continuing Operations | 413.63% | -72.20% | -75.51% | -72.05% | -78.43% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 413.63% | -72.20% | -75.51% | -72.05% | -78.43% |
| EBIT | 221.98% | -45.57% | -52.43% | -56.77% | -63.26% |
| EBITDA | 95.28% | -34.07% | -37.07% | -39.09% | -43.96% |
| EPS Basic | 419.21% | -72.73% | -76.00% | -72.55% | -78.83% |
| Normalized Basic EPS | 189.98% | -42.92% | -49.92% | -52.06% | -58.41% |
| EPS Diluted | 428.53% | -73.45% | -76.35% | -72.95% | -79.25% |
| Normalized Diluted EPS | 192.00% | -42.94% | -50.02% | -52.18% | -58.59% |
| Average Basic Shares Outstanding | 0.34% | 0.31% | 0.54% | 0.53% | 0.49% |
| Average Diluted Shares Outstanding | 0.35% | -0.10% | 0.23% | 0.22% | 0.24% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |